Clinical Trial Update: HTX-011 Administration Study in Planned Caesarean Section Procedure [Phase 2]

View source ↗

Summary

Phase 2 trial update for HTX-011 administration in planned cesarean section procedures has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Analgesia

Drugs mentioned

• HTX-011

Snippet

Sponsor: Heron Therapeutics | Conditions: Analgesia | Phase 2 | Status: COMPLETED